Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-013893

Options or other derivatives

  • President & Co-CEO acquired 544,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Chirag K. President & Co-CEO 2026-03-02 Grant or award · Restricted Stock Units +190,632 190,632 D
Patel Chirag K. President & Co-CEO 2026-03-02 Grant or award · Performance-Based Restricted Stock Units +354,031 354,031 D
Loading xslF345X05/wk-form4_1772573340.xml…